Over 10 years we helping companies reach their financial and branding goals. Onum is a values-driven SEO agency dedicated.


Imatinib intermediates manufacturers

A.R.Life Science has a significant name as the best Imatinib intermediates manufacturers. We follow strict GMP and ICH standards. We deliver superior quality products and have a dedicated Research and development team to create the best products at competitive prices. We develop both customized and standard packages depending on our customer requirements. To maintain great quality as Imatinib intermediates manufacturers we have committed staff and we follow stringent guidelines.
We established in 2007, are an ISO 9001:2015 certified organization. Imatinib is developed as a small molecule used in the treatment of certain types of cancer. It is utilized in chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and also in treating a number of other cancerous cells. It is the first in the class of inhibiting agents that act particularly on tyrosine kinase enzymes. All our products are available in powdered form, with 100gms as the minimum quantity of order.

Imatinib intermediate is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow. They act as chemical messengers. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing.


Imatinib intermediate
  • Product Features
  • Advantages
  • Applications
  • Specifications
  • Form: Powder
  • Minimum order quantity: 100gram
  • Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
  • Usage/Application: Commercial
  • Manufacturer: A. R. Life sciences Pvt Ltd.

Imatinib Intermediates Specifications:

Intermediate CAS No API/End Use Status Purity
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine 152460-10-1 Imatinib Commercial 99.5%
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride 106261-49-8 Imatinib Commercial 99.45%
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine 152460-09-8 Imatinib Commercial